Showing 1 - 2 results of 2 for search 'Mi Meng', query time: 0.01s Refine Results
  1. 1
    Case report: A sustained survival benefit of third-line immunotherapy for refractory thymic carcinoma

    Case report: A sustained survival benefit of third-line immunotherapy for refractory thymic carcinoma by Mi Meng, Bo Yu, Jie Luo, Yuju Bai, Lin Li, Shicheng Chen, Sisi He, Hu Ma

    Published 2024-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Sintilimab + Nab-PP Combined with Recombinant Human Vascular Endothelial Inhibitor for Locally Advanced/Advanced and Recurrent Metastatic Squamous Non-Small Cell Lung Cancer: Study Protocol for a Single-Arm, Multi-Centre Phase II Clinical Study

    Sintilimab + Nab-PP Combined with Recombinant Human Vascular Endothelial Inhibitor for Locally Advanced/Advanced and Recurrent Metastatic Squamous Non-Small Cell Lung Cancer: Study... by Junzhu Xu MS, Mi Meng MS, Sisi He PhD, Shixiang Wang PhD, Jie Peng PhD, Biao Yao MS, Yi Li MS, Yong Hu MS, Xiaobin Qian BS, Tianwu Wang BS, Hu Ma PhD, Jian-guo Zhou PhD

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: